Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen, Inc. - Common Stock (NQ: OCGN )

0.7179 +0.0152 (+2.16%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
33 34 Next >
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
Where Will Ocugen Be in 3 Years?
Most likely in the doldrums, but it could be temporary. 
Via The Motley Fool
Exposures COVID-19
Ocugen Stock Looks Poised to Take a Tumble Right Here
After WHO granted Covaxin a limited Emergency Use Listing, many institutions and hedge funds are likely to sell or short OCGN stock. 
Via InvestorPlace
Exposures COVID-19 Product Safety
Is Ocugen a Buy?
It'll take more than regulatory approvals of its vaccine for it to become a good investment. 
Via The Motley Fool
Exposures COVID-19
Ocugen Seeks FDA Emergency Use Nod For Covaxin COVID-19 Vaccine In Kids
Ocugen Inc (NASDAQ: OCGN) said that it sent a request to the FDA for an emergency authorization for its COVID-19 vaccine candidate BBV152, known as Covaxin outside... 
Via Benzinga
Exposures COVID-19 Product Safety
With Ocugen Stock: Follow The Lead of Traders and ‘Sell The News’
WHO approval for Covaxin doesn't change the game much for OCGN stock, steer clear as it slides back to lower prices. 
Via InvestorPlace
Exposures COVID-19
Here's Why Shares of Moderna, Novavax, and Ocugen Have All Been Extremely Volatile This Week
Multiple earnings reports and regulatory updates shook up the coronavirus vaccine space this week. 
Via The Motley Fool
Exposures COVID-19
The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus NRx's COVID-19 Drug Fails to Get Authorization From FDA Due To... 
Via Benzinga
Exposures COVID-19 Product Safety
This Surprising FDA Announcement Could Be Huge for Ocugen
The agency will allow vaccine boosters to be mixed and matched. 
Via The Motley Fool
Exposures Product Safety
Is Ocugen's Surge Much Ado About Nothing?
The short answer: Yes. 
Via The Motley Fool
Exposures COVID-19
Avoid Ocugen — The Vaccine Is Too Little, Too Late
With high percentage of vaccination in U.S. and Canada, Ocugen has a limited addressable market. Limited cash flow visibility from vaccine. With the company still waiting for official FDA approval for... 
Via InvestorPlace
Exposures Product Safety
81 Biggest Movers From Yesterday
Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares jumped 95.1% to close at $12.68 on Thursday after dropping over 10% on Wednesday. TDH Holdings, Inc. (NASDAQ: PETZ) jumped 79.8... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Evaxion Biotech (NASDAQ:EVAX) stock moved upwards by 157.5% to $16.74 during Thursday's regular session. Evaxion Biotech's stock is trading at a volume of... 
Via Benzinga
55 Stocks Moving In Thursday's Mid-Day Session
Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares climbed 179% to $18.17 after dropping over 10% on Wednesday. NerdWallet, Inc. (NASDAQ: NRDS) jumped 60% to $28.86 after the... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Evaxion Biotech (NASDAQ:EVAX) shares increased by 244.61% to $22.4 during Thursday's pre-market session. The company's market cap stands at $430.0 million... 
Via Benzinga
4 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to... 
Via Benzinga
24 Stocks Moving in Thursday's Pre-Market Session
Gainers Evaxion Biotech A/S (NASDAQ: EVAX) rose 143.5% to $15.83 in pre-market trading after dropping over 10% on Wednesday. TDH Holdings, Inc. (NASDAQ: PETZ) rose 72.6% to $4.09... 
Via Benzinga
Ocugen Neared $16 Yesterday, But I’ll Eat 4 Hats If It Gets to $32
OCGN stock has moved higher despite little evidence anything’s changed regarding Ocugen’s revenue potential in the U.S. 
Via InvestorPlace
Exposures COVID-19
86 Biggest Movers From Yesterday
Gainers FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire Fazoli’s Restaurant Chain for $130 million.... 
Via Benzinga
Most Active Equity Options For Midday - Wednesday, Nov. 3
Top Tickers: TSLA, AMC, AMD, AAPL, F, BBBY, LCID, GME, BB, NVDA, Z, UBER, PLTR, HOOD, OCGN, AAL, ATVI, SOFI, PFE, FB. 
Via Talk Markets
Why Ocugen Stock Is Falling Today
The biotech received some good news for its most important product. So why is the stock down? 
Via The Motley Fool
Exposures COVID-19
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers iRhythm Technologies (NASDAQ:IRTC) stock moved upwards by 52.78% to $117.34 during Wednesday's regular session. iRhythm Technologies's stock is trading at... 
Via Benzinga
BZ Chart Of The Day: Will Ocugen Remember?
They say that markets have memories. It’s true, and holders and traders of Ocugen, Inc. (NASDAQ: 
Via Benzinga
Ocugen's India Partnered COVID-19 Vaccine Gets WHO Approval: Report
WHO's Technical Advisory Group has recommended the Emergency Use Listing status for Bharat Biotech's COVID-19, Covaxin. Read Next: Ocugen Reverses Course From Monday... 
Via Benzinga
Exposures COVID-19
Here's Why Ocugen Stock Skyrocketed 64.9% in October
The biotech stock is now up a staggering 756% year to date. 
Via The Motley Fool
Exposures COVID-19
OCGN Stock Alert: WHO Issues Emergency-Use Listing for Covaxin
The WHO has finally given Covaxin emergency approval, putting OCGN stock in the spotlight. Will Ocugen be able to bring doses to the U.S.? 
Via InvestorPlace
Exposures COVID-19
3 Explosive Biotech Stocks -- Could They Shoot Even Higher?
These biotech stocks have recently been responsible for a slew of rocketship emojis. 
Via The Motley Fool
PFE Stock Alert: 3 Catalysts Giving Pfizer Stock a Shot in the Arm Today
Pfizer is getting ready to start shipping children's vaccines, and PFE stock is rising. That's not the only good news for investors, though. 
Via InvestorPlace
OCGN Stock Alert: Why Ocugen Shares Are Drawing Eyes Ahead of Nov. 3
A key WHO ruling that could materialize as soon as tomorrow has investors considering where OCGN stock could be headed this week. 
Via InvestorPlace
Exposures COVID-19
Check Out What Whales Are Doing With OCGN
Someone with a lot of money to spend (and possibly insider knowledge) has taken a bearish stance on Ocugen (NASDAQ:OCGN). And retail traders should know. We noticed this today... 
Via Benzinga
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.